Matthew Paul Kowalsky serves as Executive at PROTEON THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Matthew Paul Kowalsky has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 11, 2023 involved selling 1,925 shares valued at $0.
Matthew Paul Kowalsky currently holds 29,479 shares of PROTEON THERAPEUTICS INC (PRTO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Paul Kowalsky has been a net neutral trader of PRTO stock. They have purchased $0 and sold $0 worth of shares.
Matthew Paul Kowalsky's most recent insider trade was on Aug 11, 2023, when they sold 1,925 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.93 |
| Discretionary |
| Jun 29, 2018 | PRTO | $16.2K | Award | 10,000 | $1.62 | Discretionary |
| Dec 29, 2017 | PRTO | $5.1K | Award | 3,934 | $1.30 | Discretionary |
| Jun 30, 2017 | PRTO | $13.0K | Award | 10,000 | $1.30 | Discretionary |